Status:
TERMINATED
Mindfulness Based Stress Reduction in Rheumatic Diseases
Lead Sponsor:
Johns Hopkins University
Conditions:
Rheumatoid Arthritis
Psoriatic Arthritis
Eligibility:
All Genders
18-100 years
Brief Summary
This study will assess the mental health and clinical benefits of Mindfulness Based Stress Reduction (MBSR) in patients with rheumatic disease who have anxiety or depression. MBSR, an interactive form...
Detailed Description
Participation in the study entails completing a baseline and 1-month post MBSR follow up research appointment. A baseline research appointment must occur within 30 days (+/- 15 days) of the MBSR start...
Eligibility Criteria
Inclusion
- Established patients in the Johns Hopkins Bayview Rheumatology clinic
- Rheumatoid Arthritis per the American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR) 2010 classification criteria
- Psoriatic Arthritis per the Classification Criteria for Psoriatic Arthritis (CASPAR) or physician-diagnosis
- Scleroderma per the ACR/EULAR 2013 classification criteria or physician-diagnosis
- New onset of Comorbid anxiety and/or depression
- Participants must speak English
- Participants must be able to attend a weekly (8 weeks total) Mindfulness Based Stress Reduction course as well as routine follow up appointments in the rheumatology clinic
- Participants must have insurance
Exclusion
- Patients who routinely perform mindfulness based practices and any other form of meditation, including moving meditations such as yoga
- Patients who are not physically able to sit through weekly sessions that are 2.5 hours in length or a final meditative retreat of 4-hours duration
- Patients with alcohol or substance use disorders within the past 6 months
- Current, or previous history of psychotic disorders or bipolar disorder
- Patients who are actively suicidal
- Patients on greater than 10 mg of prednisone daily on a chronic basis.
Key Trial Info
Start Date :
January 18 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 22 2021
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT03411057
Start Date
January 18 2018
End Date
April 22 2021
Last Update
April 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Asthma and Allergy Center
Baltimore, Maryland, United States, 21224